Background: The diagnostic yield of coeliac disease could be improved by screening in at-risk groups, but long-term benefits of this approach are obscure. Objective: To investigate health, quality of life and dietary adherence in adult coeliac patients diagnosed in childhood by screening. Methods: After thorough evaluation of medical history, follow-up questionnaires were sent to 559 adults with a childhood coeliac disease diagnosis. The results were compared between screen-detected and clinically-detected patients, and also between originally asymptomatic and symptomatic screen-detected patients. Results: In total, 236 (42%) patients completed the questionnaires a median of 18.5 years after childhood diagnosis. Screen-detected patients (n ¼ 48) had coeliac disease in the family and type 1 diabetes more often, and were less often smokers and members of coeliac societies compared to clinically-detected patients, whereas the groups did not differ in current self-experienced health or health concerns, quality of life or dietary adherence. Screen-detected, originally asymptomatic patients had more anxiety than those presenting with symptoms, whereas the subgroups were comparable in other current characteristics. Conclusion: Comparable long-term outcomes between screen-detected and clinically-detected patients support risk-group screening for coeliac disease. However, asymptomatic patients may require special attention.
Introduction
Over recent decades, coeliac disease has become a common health problem affecting up to 1-3% of the population. 1, 2 Unfortunately, due to the diverse clinical presentation, most sufferers remain undiagnosed. 1, 2 Diagnostic efficiency could be improved by risk-group screening, for example among relatives of patients and those with type 1 diabetes. 3 Supporting early diagnosis, screen-detected children may already have advanced disease and a subsequent risk of permanent complications such as impaired growth and reduced bone accrual. [4] [5] [6] [7] Delaying diagnosis until later adulthood predisposes to even more severe maladies, including osteoporotic fractures and refractory coeliac disease. 8 Counterweighting the benefits of screening is the burden of demanding treatment. Adhering to a glutenfree diet may negatively affect the quality of life, especially in asymptomatic patients with satisfactory health prior to diagnosis. 9 Despite these challenges, there is some evidence from short-term follow-up studies that these children can achieve good dietary adherence and quality of life. 7, [10] [11] [12] However, long-term data in screendetected coeliac disease patients are very limited. 13, 14 It is possible that in puberty, the initial ''honeymoon period'' fades concurrently with the new challenges in life, leading to poor compliance and ill-health. 15, 16 The paucity of long-term studies has led to prudence when it comes to screening recommendations. 17 In the present study, we investigated long-term health and treatment outcomes in adult coeliac disease patients diagnosed in childhood. We were particularly interested in patients detected by at-risk group screening, including those with no apparent symptoms.
Methods

Patients and study design
The study was conducted in the Tampere Center for Child Health Research. Data were constructed by combining patients' answers to questionnaires and personal health information collected from medical records, and, in some cases, by interviews carried out in the context of an earlier study. 18 The basic cohort comprised 1070 patients gathered from our research database, 18 supplemented by a search with selected diagnosis codes possibly indicating coeliac disease in the patient records of Tampere University Hospital, (Figure 1 ) a tertiary center with a catchment area of &120,000 children. Patients who were diagnosed <18 years of age during 1966-2014 were included for further assessment. After evaluation of medical records, 115 patients were found to be deceased and/or to have an uncertain diagnosis. Of the remaining 955 patients with a proven childhood diagnosis, 559 were currently alive and 18 years and were sent the study questionnaires. A repeat questionnaire was sent to all non-responders after 2 months (Figure 1 ).
For the subsequent analyses, the responders were divided into: (a) those diagnosed via risk-group screening including patients suffering from type 1 diabetes or other concomitant autoimmune disease, or having relatives with coeliac disease, and (b) those found due to clinical suspicion. Screen-detected patients were further classified into asymptomatic and symptomatic based on the evaluation of symptoms at diagnosis before All database patients a n =1070
Incorrect/unclear diagnosis b , n= 109 No data, n=6
Diagnosis in childhood n=955
Current age ≥18 years n =585
Current age <18 years, n= 370
No contact, n =19 Deceased, n=7
Questionnaires sent n=559
No response, n= 322
Response n=237 Figure 1 . Flowchart of the study. a Patients were gathered from our research database and supplemented by a search in the patient records with ICD-7-10 diagnosis codes K90.0, 579A, 579.0, 269.00, 269.98 and 286.00 possibly indicating coeliac disease. Patients with an incorrect diagnosis code were found to have, for example, haemophilia A, cow's milk allergy, primary lactose intolerance or von Willerbrandt disease.
initiation of a gluten-free diet. All study variables were compared between the above-mentioned groups. Altogether, 110 healthy adults comprised the control group for comparison of current symptoms and quality of life. 19 Their median age was 49 (range 23-87) years and 81% were females. Controls were recruited among the friends and close neighborhood of known coeliac disease patients. None of the controls had suspicion of coeliac disease or known coeliac disease in close relatives.
Medical history
Medical data were collected regarding the clinical and histological presentation of coeliac disease at the time of diagnosis. Information was gathered on the main reason for coeliac disease suspicion and presence of gastrointestinal or extra-intestinal symptoms. Furthermore, possible complications, as well as the presence of coeliac disease-related or other coexisting diseases, and coeliac disease in first-degree relatives were noted. Abnormalities in laboratory values or physicians' examinations were also recorded, but were considered as signs instead of symptoms.
Poor growth was defined as disturbed height and/or weight development compared to expected growth as described in detail elsewhere. 5 Body mass index was calculated as height/weight 2 (kg/m 2 ). Anaemia at diagnosis was defined based on the age-and genderdependent reference values for haemoglobin.
Severity of histological damage was classified based on the pathological report. In our hospital practice, the degree of villous atrophy is evaluated from several well-oriented biopsy samples and further categorized as partial, subtotal or total (Marsh IIIa-c).
Questionnaires
Adult patients completed three surveys, including a specifically designed study questionnaire and two questionnaires evaluating gastrointestinal symptoms and quality of life.
The study questionnaire comprised items on sociodemographic and lifestyle characteristics such as work and study situation, membership of a coeliac society, regularity of physical exercise, smoking, the presence of children and coeliac disease in the family. The presence of coeliac-related comorbidities and other chronic diseases was evaluated. Current self-experienced health was categorized as excellent, good, moderate or poor, and concerns about health as none/minor or moderate/ severe. Furthermore, patients reported their experiences of self-assessed possibly coeliac disease-related symptoms and everyday life restrictions caused by the treatment. Adherence to a gluten-free diet was classified as strict, occasional lapses, regular lapses or no diet, and the frequency of follow-up as regular or none/very occasional.
The Psychological General Well-Being (PGWB) questionnaire evaluates health-related quality of life, which is subsequently divided into anxiety, depression, positive well-being, self-control, general health and vitality. 20 Altogether, 22 questions are rated from 1 to 6, with higher scores representing better well-being. The total score is the sum of all scores, with the values being between 22 and 132, and the subdimensions are calculated as sums of scores of selected questions. For example, vitality describes a person's energy level, and the score represents the sum of questions about overall energy, activity, tiredness, and experience of resting after a night's sleep. 20 The Gastrointestinal Symptom Rating Scale (GSRS) consists of 15 questions, which evaluate common gastrointestinal symptoms and their severity. 21 Each question is scored via a seven-point Likert scale from asymptomatic (1) to severe symptoms (7) . The total score is calculated as a mean of all 15 items. Further, the questions are divided to five subdimensionsabdominal pain, indigestion, diarrhoea, constipation and reflux -which are calculated as means of selected questions.
Ethical aspects
The Regional Ethics Committee of Tampere University Hospital approved the research protocol (Ethical committee code R16091, 31 May 2016), and ethical guidelines of the 1975 Declaration of Helsinki were followed. Patients participating in earlier interviews or answering the questionnaires fulfilled informed consent.
Statistics
Non-parametric numeric values are reported as medians with quartiles, and compared between the groups with Mann-Whitney U or Kruskal-Wallis tests. Bonferroni correction was used in pair-wise post hoc comparisons. Categorized values are reported as numbers and percentages, and compared via 2 or Fisher's exact tests. Significance was set at p value < 0.05. Statistical analyses were carried out with SPSS version 23 (IBM Corporation, Armonk, NY). Data were available for > 90% of patients unless otherwise stated.
Results
Altogether, 237 (42%) currently adult patients answered the questionnaires (Figure 1 ). The responders were more often girls, suffered type 1 diabetes less frequently and had more coeliac disease in the family than the non-responders (n ¼ 322), while the groups did not differ significantly in other diagnostic variables such as clinical presentation and the main reason for diagnostic evaluation (eTable 1).
Of 236 responders with available information on diagnostic approach, 48 (20%) had been found by screening and 188 (80%) due to clinical suspicion (Table 1) . Screen-detected patients were diagnosed at a significantly older age and more recently. They also had fewer symptoms and growth disturbances at diagnosis, but although their haemoglobin levels were higher, there was no significant difference between the groups in the presence of anaemia. The groups were also comparable in gender and degree of villous atrophy (Table 1) .
In subgroup analysis, screen-detected patients presenting with symptoms at diagnosis (n ¼ 21) were younger (9.5 vs 12.1 years, p ¼ 0.098) and more often girls (86 vs 56%, p ¼ 0.025), and had more anaemia (33 vs 7%, p ¼ 0.031) than asymptomatic subjects (n ¼ 27). The subgroups did not differ in the year of diagnosis, presence of growth disturbances, median haemoglobin or degree of villous atrophy (data not shown).
In current comparison at a median of 18.5 years (interquartile range ¼ 12.7, 30.7 years) after the diagnosis, the presence of coeliac disease in the family and type 1 diabetes were more common in screen-detected patients, whereas they were less often members of coeliac societies or current smokers than those found due to clinical suspicion ( Table 2 ). The groups were comparable in age, work and study situation, the presence of other concomitant diseases and children, frequency of physical exercise and body composition (Table 2) , as well as in experienced health, concerns about health, presence of symptoms, daily restrictions caused by the treatment, dietary adherence and the implementation of follow-up (Table 3 ). There were no differences between the subgroups of symptomatic and asymptomatic patients in the aforementioned variables (Table 4) .
Screen-detected and clinically-detected patients were comparable with respect to current quality of life and symptoms as measured by PGWB and GSRS, but both groups showed lower vitality (Figure 2(a) ), and screendetected patients reported more abdominal pain and reflux (Figure 2(b) ), compared to non-coeliac controls. When the analyses were repeated in the subgroups, PGWB anxiety and vitality scores were lower than controls in those who were asymptomatic at diagnosis (Figure 2(c) ), while there were no differences in GSRS (data not shown). Increased anxiety was also seen in patients with non-coeliac-related co-morbidities such as malignancies, eating disorders and depression, and in smokers, whereas coexisting type 1 diabetes or thyroid disease were not associated with anxiety and it did not correlate with the time from the diagnosis (data not shown).
Discussion
Our main finding was that coeliac disease patients diagnosed in childhood by screening and due to clinical suspicion are comparable in most measured adulthood health outcomes. The results give further support to screening among at-risk children. However, a subgroup of patients asymptomatic at diagnosis are at an increased risk of later anxiety and may require special support during follow-up. Whether the benefits of screening overcome the possible burden of the dietary treatment cannot be answered with certainty by this study design, but it is important to bear in mind that asymptomatic screen-detected patients are also at risk of developing permanent complications. As regards to the rationale of screening, it was of particular importance that we found no differences in dietary adherence between screen-and clinically-detected coeliac disease patients. Earlier long-term studies investigating this issue are scant. In a study by Roma et al., 88% of screen-detected children adhered to a gluten-free diet compared to 58% of the whole-study cohort after 4 years on the diet. 22 Fabiani et al. reported a mere 23% of screen-detected adolescents maintaining a strict diet after 5 years compared to 68% of those found because of malabsorptive symptoms. 15 Besides these paediatric studies, we and Mahadev et al. have observed similar dietary adherence patterns between cohorts of screened and clinically-detected adults, in which some individuals were diagnosed as children. 23, 24 However, subjects with a childhood diagnosis were not evaluated separately. A few more adult studies have assessed adherence in originally paediatric patients, but it is unclear whether screen-detected subjects were included. 13, 25 Drawing firm conclusions from this limited number of studies is challenging, but adherence is likely to be markedly dependent on the variability of the prevailing knowledge of coeliac disease and the availability of gluten-free products. 26, 27 Furthermore, it is important to realize that Fabiani et al. published their study as far back as 2000, since which the gluten-free diet has become popular and easier to maintain. 28 More studies in different populations are needed, but we here demonstrated that, in favorable circumstances, the achievement of good long-term dietary adherence is possible in screen-detected patients. Furthermore, screened patients had similar or even better health-related behavior, when for example smoking was less common among them. However, one explanation for this could be that a higher proportion of those with type 1 diabetes were screen-detected compared to those that were clinically found, since these patients are particularly advised to avoid smoking strictly to prevent diabetes-associated long-term complications.
A gluten-free diet is necessary to achieve remission in coeliac disease, but can be challenging in many respects. Here, screen-detected and clinically identified patients did not differ in quality of life or their experience of everyday life restrictions caused by the treatment. Nevertheless, dietary restriction might be particularly burdensome in screen-detected patients, who often consider themselves healthy before the diagnosis and may lack the experience of a positive treatment response. 29, 30 Earlier, Fabiani et al. observed screen-and clinicallydetected adolescents to be comparable regarding the experience of anxiety and depression. 15 In addition, van Koppen et al. reported comparable quality of life between healthy controls and 32 screen-detected children after 10 years on a gluten-free diet.
14 However, even at that point, these patients were still in early adolescence (<15 years) and the treatment was mainly the parents' responsibility.
Clinical presentation and particularly the absence of symptoms may affect the experience of an individual with coeliac disease even more than the original reason for diagnostic evaluation. 17 Hitherto, the lack of evidence on the long-term benefits of screening, particularly in asymptomatic patients, has led to considerable caution, and, for example, the US Preventive Services Task Force has demanded more prospective studies before releasing screening recommendations. 17 However, in practice, the required studies are particularly laborious and may take decades to complete with sufficient power. Our center has a long tradition in coeliac disease research, which has enabled us to obtain a unique cohort of adults diagnosed by childhood screening from as far back as the 1970s. 18, 31 Another issue that must be considered when discussing screening is that it is not a synonym for an absence of symptoms, as many of these patients are not asymptomatic but simply unrecognized, 7, 10, 23 as was seen in almost half of our patients. As regards truly asymptomatic cases, it was noteworthy that they did not report more restrictions in daily life or most aspects of quality of life.
There are already important arguments favoring coeliac disease screening in childhood. Notwithstanding the less severe clinical presentation, we observed that screen-detected and even asymptomatic children can already have severe histological damage. This confirms our earlier findings and demonstrates that these otherwise unidentified patients are at risk of permanent complications, similarly to those found in clinical practice. 7 In fact, some asymptomatic children already had signs of anaemia and poor growth, and others have reported that such patients can suffer from osteopaenia and underachievement. 4, 32 Furthermore, although more studies are needed, an early-initiated gluten-free diet might reduce the risk of other autoimmune diseases. 33, 34 Although most of our results support childhood screening, certain challenges remain. We found an absence of symptoms to predispose to increased anxiety in adulthood, which is in accordance with our previous observation in a small subgroup of asymptomatic adults. 9 It is logical that these individuals find it difficult to adapt to the diagnosis and life-long dietary restriction, particularly if its justification is unclear. Alternatively, owing to the absence of warning symptoms, they might be afraid of inadvertent gluten exposure and the subsequent development of complications. It is therefore important to explain why treatment could be rational in asymptomatic coeliac disease, and to underline the good prognosis when dietary adherence is successful.
Strengths and limitations
The major strength of the present study is the large cohort of adults with biopsy-proven coeliac disease diagnosed in childhood. We also succeeded in collecting comprehensive medical data at diagnosis together with data on a variety of current sociodemographic, health and lifestyle factors. The use of validated questionnaires in the evaluation of symptoms and quality of life increases the reliability and generalizability of the results. 9, [19] [20] [21] 23, 27 There were also limitations. A relatively low response rate to questionnaires predisposes to selection bias. This common problem in postal surveys was likely further aggravated by the long interval between the diagnosis and the current study. For example, it is possible that patients who had better dietary adherence were more likely to answer the questionnaires and thus skewed the results. However, the fact that responders and nonresponders were comparable in most features reduces the risk of bias. Another limitation was incomplete data in a part of the study variables at the time of diagnosis. Finally, the non-coeliac controls were older and more often female than coeliac disease patients, which may have affected the comparability of quality of life. 35 
Conclusions
We have provided evidence, which was previously lacking, regarding the long-term health outcomes in screen-detected coeliac disease. Of particular importance was that even asymptomatic children can attain good adulthood quality of life while maintaining a strict gluten-free diet. However, physicians should bear in mind that, in some patients, the absence of symptoms at childhood diagnosis may predispose to later anxiety. We do not regard this as a counterargument against screening, but encourage physicians to take clinical presentation into account when planning long-term follow-up. At this point, we feel that affected children and their families at least have a right to be aware of the underlying coeliac disease and be in a position to consider treatment options. Without screening, a substantial number of sufferers remain undiagnosed, with often unrecognized symptoms and an increased risk of complications.
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